Positive control of a minimal model of tumor growth with bevacizumab treatment

Dániel András Drexler, Johanna Sápi, L. Kovács

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Citations (Scopus)

Abstract

Application of model-based control strategies for physiological control problems, like tumor therapy, may greatly improve the efficiency of clinical treatments. Our aim is to design a positive path tracking controller for a minimal model of tumor growth under angiogenic inhibition with bevacizumab treatment. We extend the dynamics of the system to ensure the positivity of the input, and design path tracking controller after exact linearization is carried out for the extended system. We carry out simulations for different reference signals for the path tracking controllers, and confirm that the tumor can be eliminated using bevacizumab therapy with physiologically feasible input signals. The resulting inputs are positive, and their maximal values are in physiologically feasible regions, thus the results may be applicable in clinical practice.

Original languageEnglish
Title of host publicationProceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages2084-2087
Number of pages4
Volume2018-February
ISBN (Electronic)9781538621035
DOIs
Publication statusPublished - Feb 5 2018
Event12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017 - Siem Reap, Cambodia
Duration: Jun 18 2017Jun 20 2017

Other

Other12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017
CountryCambodia
CitySiem Reap
Period6/18/176/20/17

Fingerprint

Path Tracking
Tumor Growth
Minimal Model
Tumors
Controller
Controllers
Therapy
Tumor
Model-based Control
Extended Systems
Feasible region
Linearization
Positivity
Control Strategy
Control Problem
Simulation
Design

ASJC Scopus subject areas

  • Control and Optimization
  • Electrical and Electronic Engineering
  • Industrial and Manufacturing Engineering

Cite this

Drexler, D. A., Sápi, J., & Kovács, L. (2018). Positive control of a minimal model of tumor growth with bevacizumab treatment. In Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017 (Vol. 2018-February, pp. 2084-2087). Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/ICIEA.2017.8283181

Positive control of a minimal model of tumor growth with bevacizumab treatment. / Drexler, Dániel András; Sápi, Johanna; Kovács, L.

Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017. Vol. 2018-February Institute of Electrical and Electronics Engineers Inc., 2018. p. 2084-2087.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Drexler, DA, Sápi, J & Kovács, L 2018, Positive control of a minimal model of tumor growth with bevacizumab treatment. in Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017. vol. 2018-February, Institute of Electrical and Electronics Engineers Inc., pp. 2084-2087, 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017, Siem Reap, Cambodia, 6/18/17. https://doi.org/10.1109/ICIEA.2017.8283181
Drexler DA, Sápi J, Kovács L. Positive control of a minimal model of tumor growth with bevacizumab treatment. In Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017. Vol. 2018-February. Institute of Electrical and Electronics Engineers Inc. 2018. p. 2084-2087 https://doi.org/10.1109/ICIEA.2017.8283181
Drexler, Dániel András ; Sápi, Johanna ; Kovács, L. / Positive control of a minimal model of tumor growth with bevacizumab treatment. Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017. Vol. 2018-February Institute of Electrical and Electronics Engineers Inc., 2018. pp. 2084-2087
@inproceedings{7bfe7564adac48eea0150bf89cd54de7,
title = "Positive control of a minimal model of tumor growth with bevacizumab treatment",
abstract = "Application of model-based control strategies for physiological control problems, like tumor therapy, may greatly improve the efficiency of clinical treatments. Our aim is to design a positive path tracking controller for a minimal model of tumor growth under angiogenic inhibition with bevacizumab treatment. We extend the dynamics of the system to ensure the positivity of the input, and design path tracking controller after exact linearization is carried out for the extended system. We carry out simulations for different reference signals for the path tracking controllers, and confirm that the tumor can be eliminated using bevacizumab therapy with physiologically feasible input signals. The resulting inputs are positive, and their maximal values are in physiologically feasible regions, thus the results may be applicable in clinical practice.",
author = "Drexler, {D{\'a}niel Andr{\'a}s} and Johanna S{\'a}pi and L. Kov{\'a}cs",
year = "2018",
month = "2",
day = "5",
doi = "10.1109/ICIEA.2017.8283181",
language = "English",
volume = "2018-February",
pages = "2084--2087",
booktitle = "Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017",
publisher = "Institute of Electrical and Electronics Engineers Inc.",

}

TY - GEN

T1 - Positive control of a minimal model of tumor growth with bevacizumab treatment

AU - Drexler, Dániel András

AU - Sápi, Johanna

AU - Kovács, L.

PY - 2018/2/5

Y1 - 2018/2/5

N2 - Application of model-based control strategies for physiological control problems, like tumor therapy, may greatly improve the efficiency of clinical treatments. Our aim is to design a positive path tracking controller for a minimal model of tumor growth under angiogenic inhibition with bevacizumab treatment. We extend the dynamics of the system to ensure the positivity of the input, and design path tracking controller after exact linearization is carried out for the extended system. We carry out simulations for different reference signals for the path tracking controllers, and confirm that the tumor can be eliminated using bevacizumab therapy with physiologically feasible input signals. The resulting inputs are positive, and their maximal values are in physiologically feasible regions, thus the results may be applicable in clinical practice.

AB - Application of model-based control strategies for physiological control problems, like tumor therapy, may greatly improve the efficiency of clinical treatments. Our aim is to design a positive path tracking controller for a minimal model of tumor growth under angiogenic inhibition with bevacizumab treatment. We extend the dynamics of the system to ensure the positivity of the input, and design path tracking controller after exact linearization is carried out for the extended system. We carry out simulations for different reference signals for the path tracking controllers, and confirm that the tumor can be eliminated using bevacizumab therapy with physiologically feasible input signals. The resulting inputs are positive, and their maximal values are in physiologically feasible regions, thus the results may be applicable in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85042231365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042231365&partnerID=8YFLogxK

U2 - 10.1109/ICIEA.2017.8283181

DO - 10.1109/ICIEA.2017.8283181

M3 - Conference contribution

AN - SCOPUS:85042231365

VL - 2018-February

SP - 2084

EP - 2087

BT - Proceedings of the 2017 12th IEEE Conference on Industrial Electronics and Applications, ICIEA 2017

PB - Institute of Electrical and Electronics Engineers Inc.

ER -